PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF SMOKING-INDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE COMPRISING ROSIGLITAZONE AS AN ACTIVE INGREDIENT

摘要

A pharmaceutical composition comprising rosiglitazone is provided to inhibit the emphysematous parenchyma destruction induced by smoking and hypertension and inhibit the infiltration of inflammatory cells. A pharmaceutical composition for preventing and treating a smoking-induced chronic obstructive pulmonary disease comprises a pharmaceutically acceptable carrier and rosiglitazone as effective ingredients. The composition further comprises a supplement such as a solvent, a disintegrator, a sweetener, a binder, a coating agent, a blowing agent, a lubricant, and a flavor.